Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33472909.
- Also identified by DOI 10.1158/1078-0432.CCR-20-4342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an innovative drug delivery technique invented to be used for the treatment of peritoneal metastasis. Its application gained popularity over the past years. Several prospective clinical trials are being conducted to determine efficacy and safety. At this moment, there remain many challenges to overcome before PIPAC can be widely adopted in clinical practice.<i>See related article by Kim et al., p. 1875</i>.
Medical subject headings
- Peritoneal Neoplasms